Strategic design and development of a siderophore mimic: pioneering anticancer therapy via ROS generation and ferroptosis
We designed a tris-catecholate-based siderophore mimic, H6-T-CATL, to selectively chelate
iron (III) from mitochondrial cytochromes and other iron-containing proteins within cellular …
iron (III) from mitochondrial cytochromes and other iron-containing proteins within cellular …
A New Hetero‐Bimetallic [Fe (III)‐Mn (I)] Complex as a Dual Modality, Theranostic Tool for Photoactivated Anticancer Therapy
A Panwar, A Upadhyay, M Mukherjee… - Applied …, 2024 - Wiley Online Library
We developed a novel hetero‐bimetallic Fe (III)‐Mn (I) complex by combining hydroxyl
radicals generating Fe (III)‐Phenolato/Carboxylato and CO‐releasing Mn (I)(CO) 3 …
radicals generating Fe (III)‐Phenolato/Carboxylato and CO‐releasing Mn (I)(CO) 3 …